Opaleye Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-80,000
| Closed | -$6.11M | – | 53 |
|
|
2018
Q3 | $6.11M | Hold |
80,000
| – | – | 1.55% | 23 |
|
|
2018
Q2 | $6.15M | Hold |
80,000
| – | – | 1.59% | 24 |
|
|
2018
Q1 | $4.08M | Sell |
80,000
-10,000
| -11% | -$510K | 1.17% | 24 |
|
|
2017
Q4 | $4.17M | Buy |
+90,000
| New | +$4.17M | 1.34% | 23 |
|
|
2016
Q4 | – | Sell |
-35,000
| Closed | -$2.48M | – | 45 |
|
|
2016
Q3 | $2.48M | Sell |
35,000
-30,000
| -46% | -$2.13M | 1.3% | 29 |
|
|
2016
Q2 | $3.18M | Sell |
65,000
-45,000
| -41% | -$2.2M | 2.12% | 16 |
|
|
2016
Q1 | $6.96M | Hold |
110,000
| – | – | 4.34% | 3 |
|
|
2015
Q4 | $12.3M | Hold |
110,000
| – | – | 5.16% | 1 |
|
|
2015
Q3 | $10.6M | Hold |
110,000
| – | – | 5.21% | 2 |
|
|
2015
Q2 | $11.3M | Hold |
110,000
| – | – | 4.48% | 6 |
|
|
2015
Q1 | $6.83M | Buy |
110,000
+3,800
| +4% | +$236K | 3.17% | 11 |
|
|
2014
Q4 | $4.66M | Buy |
106,200
+21,200
| +25% | +$930K | 2.35% | 13 |
|
|
2014
Q3 | $4.81M | Buy |
85,000
+40,000
| +89% | +$2.26M | 3.75% | 9 |
|
|
2014
Q2 | $2.02M | Buy |
+45,000
| New | +$2.02M | 1.74% | 16 |
|